查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1874465

藥品初級內包裝：全球市佔率及排名、總收入及需求預測（2025-2031年）

Pharmaceutical Primary Inner Packaging - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 155 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球藥品初級包裝市場預計在 2024 年達到 412.55 億美元，預計到 2031 年將達到 599.38 億美元，2025 年至 2031 年的複合年成長率為 5.4%。

藥品初級內包裝是指與藥品（例如藥物、疫苗和其他醫療產品）直接接觸的材料和容器。這種包裝旨在保護產品免受污染、潮濕、光照、空氣和物理損傷等外部因素的影響，同時確保產品在其保存期限內保持其有效性、穩定性和安全性。

近年來，全球醫藥初級內包裝市場保持穩定成長，主要受生物製藥行業的擴張、創新藥物研發的加速以及學名藥需求不斷成長的推動。在此背景下，預填充式注射器（PFS）、管瓶、安瓿瓶和泡殼包裝是主流包裝形式，而可生物分解材料和智慧包裝則成為新興趨勢。

藥品內包裝的主要需求來源為注射、生物製藥及口服固體製劑。隨著單株抗體和mRNA疫苗等生物製藥的興起，對具有阻隔性和低吸附性的包裝材料的需求日益成長。此外，個人化醫療和居家醫療的發展趨勢也推動了小容量包裝（例如單劑量眼藥水和預填充注射筆）市場的成長。

按地區分類：

美國憑藉其強大的生物製藥產業和嚴格的FDA監管，推動了對高性能初級包裝材料（例如無菌注射器和特殊聚合物瓶）的需求。歐洲市場已趨於成熟，德國和瑞士等國的高附加價值藥品依賴高規格玻璃瓶和橡膠密封。歐盟永續法規（例如SUPD）正在促進可回收鋁塑複合薄膜和生物基塑膠的使用。亞太地區正經歷最快的成長。中國和印度受益於學名藥出口和國內創新藥的崛起，推動了對玻璃安瓿和塑膠薄膜的快速需求。日本的老齡化社會為便捷包裝（例如易撕鋁箔）提供了巨大的市場潛力。

市場發展機會：

單株抗體、細胞療法和其他產品需要超低吸附包裝，這催生了客製化解決方案的需求。歐盟的「綠色新政」和美國食品藥物管理局（FDA）的可回收性指南正在推動可生物分解包裝的發展。物聯網（IoT）技術的應用（例如溫度記錄標籤）提高了藥品的可追溯性，尤其對於依賴低溫運輸的疫苗更是如此。東南亞地區（例如印尼和越南）日益完善的GMP認證系統為包裝供應商帶來了新的成長機會。

市場風險與挑戰：

原料價格波動：硼矽酸玻璃依賴天然氣能源（歐洲能源危機加劇了成本壓力）；監管障礙：美國藥典<660>和歐盟藥典收緊了對可萃取物/可浸出物（E&L）的要求，增加了中小企業的合規成本；替代技術的威脅對傳統包裝技術（例如冷凍乾燥包裝劑）可能會減少對傳統包裝劑的需求。

本報告旨在按地區/國家、類型和應用對全球醫藥初級內包裝市場進行全面分析，重點關注總收入、市場佔有率和主要企業的排名。

本報告以銷售收入為指標，提供藥品初級內包裝市場規模、估算和預測，以2024年為基準年，並包含2020年至2031年的歷史數據和預測數據。透過定量和定性分析，我們幫助讀者制定業務/成長策略，評估市場競爭格局，分析自身在當前市場中的地位，並就藥品初級內包裝做出明智的商業決策。

市場區隔

公司

  • West Pharmaceutical Services
  • Gerresheimer
  • AptarGroup
  • Stevanato Group
  • Amcor
  • Shandong Pharmaceutical
  • Constantia Flexibles
  • Schott Pharma
  • Berry Global
  • SGD Pharma
  • Nipro
  • Shandong Weigao Group
  • BD
  • HySum
  • Chengdu Jingu Pharma-Pack Co.,Ltd
  • Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd
  • Gerresheimer Shuangfeng
  • Jinghua Group
  • Linuo Pharmaceutical Packaging
  • Jiyuan Zhengyu
  • EHUA

按類型分類的細分市場

  • 玻璃包裝
  • 塑膠包裝
  • 金屬包裝

應用領域

  • 生物製藥
  • 化學品和製藥

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Pharmaceutical Primary Inner Packaging was estimated to be worth US$ 41255 million in 2024 and is forecast to a readjusted size of US$ 59938 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.

Pharmaceutical Primary Inner Packaging refers to the materials and containers that come into direct contact with the pharmaceutical product (such as drugs, vaccines, or other medical products). This packaging is designed to protect the product from external factors like contamination, moisture, light, air, and physical damage while also ensuring that the product maintains its efficacy, stability, and safety throughout its shelf life.

In recent years, the global Pharmaceutical Primary Inner Packaging market has maintained steady growth, mainly driven by the expansion of the biopharmaceutical industry, the acceleration of innovative drug research and development, and the rising demand for generic drugs. Among them, prefilled syringes (PFS), vials, ampoules and blister packaging dominate, while biodegradable materials and smart packaging have become emerging trends.

The core demand for Pharmaceutical Primary Inner Packaging comes from injections, biologics and oral solid preparations, especially the rise of biopharmaceuticals such as monoclonal antibodies and mRNA vaccines, which has driven the demand for high-barrier and low-adsorption packaging materials. In addition, the trend of personalized medicine and home medication has led to the growth of the market for small-dose packaging (such as single-dose eye drops and prefilled injection pens).

Regionally:

The United States, with its strong biopharmaceutical industry and strict FDA regulations, is driving demand for high-end primary packaging materials (such as sterile syringes and specialty polymer bottles). The European market is mature, and high-value-added drugs in countries such as Germany and Switzerland rely on high-specification glass bottles and rubber seals. The EU's sustainable development regulations (such as SUPD) promote the application of recyclable aluminum-plastic composite films and bio-based plastics. The Asia-Pacific region has the fastest growth. China and India have benefited from the export of generic drugs and the rise of local innovative drugs, and the demand for glass ampoules and plastic films has surged. Due to the aging society in Japan, the market potential for convenient packaging (such as tear-off aluminum foil) is huge.

Market development opportunities:

Monoclonal antibodies, cell therapies, etc. require ultra-low adsorption packaging materials, giving rise to customized solutions. The EU's "Green Deal" and FDA's recyclability guidelines have driven companies to develop biodegradable packaging materials. Internet of Things (IoT) integration (such as temperature recording labels) improves drug traceability, especially for cold chain-dependent vaccines. GMP certification upgrades in Southeast Asia (such as Indonesia and Vietnam) provide new growth points for packaging material suppliers.

Market risks and challenges:

Raw material fluctuations: Borosilicate glass is dependent on natural gas energy (European energy crisis exacerbates cost pressure). Regulatory barriers: USP<660> and EU EP have stricter requirements on extractables/leachables (E&L), and the compliance costs of small and medium-sized enterprises are rising. Substitution threats: Packaging-free technologies (such as freeze-dried oral tablets) may reduce the demand for traditional packaging.

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Primary Inner Packaging, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pharmaceutical Primary Inner Packaging by region & country, by Type, and by Application.

The Pharmaceutical Primary Inner Packaging market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Primary Inner Packaging.

Market Segmentation

By Company

  • West Pharmaceutical Services
  • Gerresheimer
  • AptarGroup
  • Stevanato Group
  • Amcor
  • Shandong Pharmaceutical
  • Constantia Flexibles
  • Schott Pharma
  • Berry Global
  • SGD Pharma
  • Nipro
  • Shandong Weigao Group
  • BD
  • HySum
  • Chengdu Jingu Pharma-Pack Co.,Ltd
  • Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd
  • Gerresheimer Shuangfeng
  • Jinghua Group
  • Linuo Pharmaceutical Packaging
  • Jiyuan Zhengyu
  • EHUA

Segment by Type

  • Glass Packaging
  • Plastic Packaging
  • Metal Packaging

Segment by Application

  • Biopharmaceuticals
  • Chemical Pharmaceuticals

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Pharmaceutical Primary Inner Packaging company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Pharmaceutical Primary Inner Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Pharmaceutical Primary Inner Packaging in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Pharmaceutical Primary Inner Packaging Product Introduction
  • 1.2 Global Pharmaceutical Primary Inner Packaging Market Size Forecast (2020-2031)
  • 1.3 Pharmaceutical Primary Inner Packaging Market Trends & Drivers
    • 1.3.1 Pharmaceutical Primary Inner Packaging Industry Trends
    • 1.3.2 Pharmaceutical Primary Inner Packaging Market Drivers & Opportunity
    • 1.3.3 Pharmaceutical Primary Inner Packaging Market Challenges
    • 1.3.4 Pharmaceutical Primary Inner Packaging Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Pharmaceutical Primary Inner Packaging Players Revenue Ranking (2024)
  • 2.2 Global Pharmaceutical Primary Inner Packaging Revenue by Company (2020-2025)
  • 2.3 Key Companies Pharmaceutical Primary Inner Packaging Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Pharmaceutical Primary Inner Packaging Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Pharmaceutical Primary Inner Packaging
  • 2.6 Pharmaceutical Primary Inner Packaging Market Competitive Analysis
    • 2.6.1 Pharmaceutical Primary Inner Packaging Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Pharmaceutical Primary Inner Packaging Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Primary Inner Packaging as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Glass Packaging
    • 3.1.2 Plastic Packaging
    • 3.1.3 Metal Packaging
  • 3.2 Global Pharmaceutical Primary Inner Packaging Sales Value by Type
    • 3.2.1 Global Pharmaceutical Primary Inner Packaging Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Pharmaceutical Primary Inner Packaging Sales Value, by Type (2020-2031)
    • 3.2.3 Global Pharmaceutical Primary Inner Packaging Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Biopharmaceuticals
    • 4.1.2 Chemical Pharmaceuticals
  • 4.2 Global Pharmaceutical Primary Inner Packaging Sales Value by Application
    • 4.2.1 Global Pharmaceutical Primary Inner Packaging Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Pharmaceutical Primary Inner Packaging Sales Value, by Application (2020-2031)
    • 4.2.3 Global Pharmaceutical Primary Inner Packaging Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Pharmaceutical Primary Inner Packaging Sales Value by Region
    • 5.1.1 Global Pharmaceutical Primary Inner Packaging Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Pharmaceutical Primary Inner Packaging Sales Value by Region (2020-2025)
    • 5.1.3 Global Pharmaceutical Primary Inner Packaging Sales Value by Region (2026-2031)
    • 5.1.4 Global Pharmaceutical Primary Inner Packaging Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
    • 5.2.2 North America Pharmaceutical Primary Inner Packaging Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
    • 5.3.2 Europe Pharmaceutical Primary Inner Packaging Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Pharmaceutical Primary Inner Packaging Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
    • 5.5.2 South America Pharmaceutical Primary Inner Packaging Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Pharmaceutical Primary Inner Packaging Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Pharmaceutical Primary Inner Packaging Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
    • 6.3.2 United States Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Pharmaceutical Primary Inner Packaging Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
    • 6.4.2 Europe Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Pharmaceutical Primary Inner Packaging Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
    • 6.5.2 China Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Pharmaceutical Primary Inner Packaging Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
    • 6.6.2 Japan Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Pharmaceutical Primary Inner Packaging Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
    • 6.7.2 South Korea Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Pharmaceutical Primary Inner Packaging Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Pharmaceutical Primary Inner Packaging Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
    • 6.9.2 India Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Pharmaceutical Primary Inner Packaging Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 West Pharmaceutical Services
    • 7.1.1 West Pharmaceutical Services Profile
    • 7.1.2 West Pharmaceutical Services Main Business
    • 7.1.3 West Pharmaceutical Services Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.1.4 West Pharmaceutical Services Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.1.5 West Pharmaceutical Services Recent Developments
  • 7.2 Gerresheimer
    • 7.2.1 Gerresheimer Profile
    • 7.2.2 Gerresheimer Main Business
    • 7.2.3 Gerresheimer Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.2.4 Gerresheimer Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Gerresheimer Recent Developments
  • 7.3 AptarGroup
    • 7.3.1 AptarGroup Profile
    • 7.3.2 AptarGroup Main Business
    • 7.3.3 AptarGroup Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.3.4 AptarGroup Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.3.5 AptarGroup Recent Developments
  • 7.4 Stevanato Group
    • 7.4.1 Stevanato Group Profile
    • 7.4.2 Stevanato Group Main Business
    • 7.4.3 Stevanato Group Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.4.4 Stevanato Group Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Stevanato Group Recent Developments
  • 7.5 Amcor
    • 7.5.1 Amcor Profile
    • 7.5.2 Amcor Main Business
    • 7.5.3 Amcor Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.5.4 Amcor Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Amcor Recent Developments
  • 7.6 Shandong Pharmaceutical
    • 7.6.1 Shandong Pharmaceutical Profile
    • 7.6.2 Shandong Pharmaceutical Main Business
    • 7.6.3 Shandong Pharmaceutical Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.6.4 Shandong Pharmaceutical Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Shandong Pharmaceutical Recent Developments
  • 7.7 Constantia Flexibles
    • 7.7.1 Constantia Flexibles Profile
    • 7.7.2 Constantia Flexibles Main Business
    • 7.7.3 Constantia Flexibles Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.7.4 Constantia Flexibles Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Constantia Flexibles Recent Developments
  • 7.8 Schott Pharma
    • 7.8.1 Schott Pharma Profile
    • 7.8.2 Schott Pharma Main Business
    • 7.8.3 Schott Pharma Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.8.4 Schott Pharma Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Schott Pharma Recent Developments
  • 7.9 Berry Global
    • 7.9.1 Berry Global Profile
    • 7.9.2 Berry Global Main Business
    • 7.9.3 Berry Global Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.9.4 Berry Global Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Berry Global Recent Developments
  • 7.10 SGD Pharma
    • 7.10.1 SGD Pharma Profile
    • 7.10.2 SGD Pharma Main Business
    • 7.10.3 SGD Pharma Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.10.4 SGD Pharma Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.10.5 SGD Pharma Recent Developments
  • 7.11 Nipro
    • 7.11.1 Nipro Profile
    • 7.11.2 Nipro Main Business
    • 7.11.3 Nipro Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.11.4 Nipro Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Nipro Recent Developments
  • 7.12 Shandong Weigao Group
    • 7.12.1 Shandong Weigao Group Profile
    • 7.12.2 Shandong Weigao Group Main Business
    • 7.12.3 Shandong Weigao Group Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.12.4 Shandong Weigao Group Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Shandong Weigao Group Recent Developments
  • 7.13 BD
    • 7.13.1 BD Profile
    • 7.13.2 BD Main Business
    • 7.13.3 BD Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.13.4 BD Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.13.5 BD Recent Developments
  • 7.14 HySum
    • 7.14.1 HySum Profile
    • 7.14.2 HySum Main Business
    • 7.14.3 HySum Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.14.4 HySum Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.14.5 HySum Recent Developments
  • 7.15 Chengdu Jingu Pharma-Pack Co.,Ltd
    • 7.15.1 Chengdu Jingu Pharma-Pack Co.,Ltd Profile
    • 7.15.2 Chengdu Jingu Pharma-Pack Co.,Ltd Main Business
    • 7.15.3 Chengdu Jingu Pharma-Pack Co.,Ltd Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.15.4 Chengdu Jingu Pharma-Pack Co.,Ltd Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.15.5 Chengdu Jingu Pharma-Pack Co.,Ltd Recent Developments
  • 7.16 Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd
    • 7.16.1 Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd Profile
    • 7.16.2 Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd Main Business
    • 7.16.3 Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.16.4 Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.16.5 Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd Recent Developments
  • 7.17 Gerresheimer Shuangfeng
    • 7.17.1 Gerresheimer Shuangfeng Profile
    • 7.17.2 Gerresheimer Shuangfeng Main Business
    • 7.17.3 Gerresheimer Shuangfeng Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.17.4 Gerresheimer Shuangfeng Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.17.5 Gerresheimer Shuangfeng Recent Developments
  • 7.18 Jinghua Group
    • 7.18.1 Jinghua Group Profile
    • 7.18.2 Jinghua Group Main Business
    • 7.18.3 Jinghua Group Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.18.4 Jinghua Group Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.18.5 Jinghua Group Recent Developments
  • 7.19 Linuo Pharmaceutical Packaging
    • 7.19.1 Linuo Pharmaceutical Packaging Profile
    • 7.19.2 Linuo Pharmaceutical Packaging Main Business
    • 7.19.3 Linuo Pharmaceutical Packaging Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.19.4 Linuo Pharmaceutical Packaging Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.19.5 Linuo Pharmaceutical Packaging Recent Developments
  • 7.20 Jiyuan Zhengyu
    • 7.20.1 Jiyuan Zhengyu Profile
    • 7.20.2 Jiyuan Zhengyu Main Business
    • 7.20.3 Jiyuan Zhengyu Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.20.4 Jiyuan Zhengyu Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.20.5 Jiyuan Zhengyu Recent Developments
  • 7.21 EHUA
    • 7.21.1 EHUA Profile
    • 7.21.2 EHUA Main Business
    • 7.21.3 EHUA Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.21.4 EHUA Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.21.5 EHUA Recent Developments

8 Industry Chain Analysis

  • 8.1 Pharmaceutical Primary Inner Packaging Industrial Chain
  • 8.2 Pharmaceutical Primary Inner Packaging Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Pharmaceutical Primary Inner Packaging Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Pharmaceutical Primary Inner Packaging Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Pharmaceutical Primary Inner Packaging Market Trends
  • Table 2. Pharmaceutical Primary Inner Packaging Market Drivers & Opportunity
  • Table 3. Pharmaceutical Primary Inner Packaging Market Challenges
  • Table 4. Pharmaceutical Primary Inner Packaging Market Restraints
  • Table 5. Global Pharmaceutical Primary Inner Packaging Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Pharmaceutical Primary Inner Packaging Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Pharmaceutical Primary Inner Packaging Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Pharmaceutical Primary Inner Packaging Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Pharmaceutical Primary Inner Packaging
  • Table 10. Global Pharmaceutical Primary Inner Packaging Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Primary Inner Packaging as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Pharmaceutical Primary Inner Packaging Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Pharmaceutical Primary Inner Packaging Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Pharmaceutical Primary Inner Packaging Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Pharmaceutical Primary Inner Packaging Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Pharmaceutical Primary Inner Packaging Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Pharmaceutical Primary Inner Packaging Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Pharmaceutical Primary Inner Packaging Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Pharmaceutical Primary Inner Packaging Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Pharmaceutical Primary Inner Packaging Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Pharmaceutical Primary Inner Packaging Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Pharmaceutical Primary Inner Packaging Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Pharmaceutical Primary Inner Packaging Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Pharmaceutical Primary Inner Packaging Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Pharmaceutical Primary Inner Packaging Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Pharmaceutical Primary Inner Packaging Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Pharmaceutical Primary Inner Packaging Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Pharmaceutical Primary Inner Packaging Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Pharmaceutical Primary Inner Packaging Sales Value, (2026-2031) & (US$ Million)
  • Table 31. West Pharmaceutical Services Basic Information List
  • Table 32. West Pharmaceutical Services Description and Business Overview
  • Table 33. West Pharmaceutical Services Pharmaceutical Primary Inner Packaging Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Pharmaceutical Primary Inner Packaging Business of West Pharmaceutical Services (2020-2025)
  • Table 35. West Pharmaceutical Services Recent Developments
  • Table 36. Gerresheimer Basic Information List
  • Table 37. Gerresheimer Description and Business Overview
  • Table 38. Gerresheimer Pharmaceutical Primary Inner Packaging Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Pharmaceutical Primary Inner Packaging Business of Gerresheimer (2020-2025)
  • Table 40. Gerresheimer Recent Developments
  • Table 41. AptarGroup Basic Information List
  • Table 42. AptarGroup Description and Business Overview
  • Table 43. AptarGroup Pharmaceutical Primary Inner Packaging Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Pharmaceutical Primary Inner Packaging Business of AptarGroup (2020-2025)
  • Table 45. AptarGroup Recent Developments
  • Table 46. Stevanato Group Basic Information List
  • Table 47. Stevanato Group Description and Business Overview
  • Table 48. Stevanato Group Pharmaceutical Primary Inner Packaging Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Pharmaceutical Primary Inner Packaging Business of Stevanato Group (2020-2025)
  • Table 50. Stevanato Group Recent Developments
  • Table 51. Amcor Basic Information List
  • Table 52. Amcor Description and Business Overview
  • Table 53. Amcor Pharmaceutical Primary Inner Packaging Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Pharmaceutical Primary Inner Packaging Business of Amcor (2020-2025)
  • Table 55. Amcor Recent Developments
  • Table 56. Shandong Pharmaceutical Basic Information List
  • Table 57. Shandong Pharmaceutical Description and Business Overview
  • Table 58. Shandong Pharmaceutical Pharmaceutical Primary Inner Packaging Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Pharmaceutical Primary Inner Packaging Business of Shandong Pharmaceutical (2020-2025)
  • Table 60. Shandong Pharmaceutical Recent Developments
  • Table 61. Constantia Flexibles Basic Information List
  • Table 62. Constantia Flexibles Description and Business Overview
  • Table 63. Constantia Flexibles Pharmaceutical Primary Inner Packaging Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Pharmaceutical Primary Inner Packaging Business of Constantia Flexibles (2020-2025)
  • Table 65. Constantia Flexibles Recent Developments
  • Table 66. Schott Pharma Basic Information List
  • Table 67. Schott Pharma Description and Business Overview
  • Table 68. Schott Pharma Pharmaceutical Primary Inner Packaging Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Pharmaceutical Primary Inner Packaging Business of Schott Pharma (2020-2025)
  • Table 70. Schott Pharma Recent Developments
  • Table 71. Berry Global Basic Information List
  • Table 72. Berry Global Description and Business Overview
  • Table 73. Berry Global Pharmaceutical Primary Inner Packaging Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Pharmaceutical Primary Inner Packaging Business of Berry Global (2020-2025)
  • Table 75. Berry Global Recent Developments
  • Table 76. SGD Pharma Basic Information List
  • Table 77. SGD Pharma Description and Business Overview
  • Table 78. SGD Pharma Pharmaceutical Primary Inner Packaging Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Pharmaceutical Primary Inner Packaging Business of SGD Pharma (2020-2025)
  • Table 80. SGD Pharma Recent Developments
  • Table 81. Nipro Basic Information List
  • Table 82. Nipro Description and Business Overview
  • Table 83. Nipro Pharmaceutical Primary Inner Packaging Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Pharmaceutical Primary Inner Packaging Business of Nipro (2020-2025)
  • Table 85. Nipro Recent Developments
  • Table 86. Shandong Weigao Group Basic Information List
  • Table 87. Shandong Weigao Group Description and Business Overview
  • Table 88. Shandong Weigao Group Pharmaceutical Primary Inner Packaging Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Pharmaceutical Primary Inner Packaging Business of Shandong Weigao Group (2020-2025)
  • Table 90. Shandong Weigao Group Recent Developments
  • Table 91. BD Basic Information List
  • Table 92. BD Description and Business Overview
  • Table 93. BD Pharmaceutical Primary Inner Packaging Products, Services and Solutions
  • Table 94. Revenue (US$ Million) in Pharmaceutical Primary Inner Packaging Business of BD (2020-2025)
  • Table 95. BD Recent Developments
  • Table 96. HySum Basic Information List
  • Table 97. HySum Description and Business Overview
  • Table 98. HySum Pharmaceutical Primary Inner Packaging Products, Services and Solutions
  • Table 99. Revenue (US$ Million) in Pharmaceutical Primary Inner Packaging Business of HySum (2020-2025)
  • Table 100. HySum Recent Developments
  • Table 101. Chengdu Jingu Pharma-Pack Co.,Ltd Basic Information List
  • Table 102. Chengdu Jingu Pharma-Pack Co.,Ltd Description and Business Overview
  • Table 103. Chengdu Jingu Pharma-Pack Co.,Ltd Pharmaceutical Primary Inner Packaging Products, Services and Solutions
  • Table 104. Revenue (US$ Million) in Pharmaceutical Primary Inner Packaging Business of Chengdu Jingu Pharma-Pack Co.,Ltd (2020-2025)
  • Table 105. Chengdu Jingu Pharma-Pack Co.,Ltd Recent Developments
  • Table 106. Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd Basic Information List
  • Table 107. Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd Description and Business Overview
  • Table 108. Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd Pharmaceutical Primary Inner Packaging Products, Services and Solutions
  • Table 109. Revenue (US$ Million) in Pharmaceutical Primary Inner Packaging Business of Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd (2020-2025)
  • Table 110. Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd Recent Developments
  • Table 111. Gerresheimer Shuangfeng Basic Information List
  • Table 112. Gerresheimer Shuangfeng Description and Business Overview
  • Table 113. Gerresheimer Shuangfeng Pharmaceutical Primary Inner Packaging Products, Services and Solutions
  • Table 114. Revenue (US$ Million) in Pharmaceutical Primary Inner Packaging Business of Gerresheimer Shuangfeng (2020-2025)
  • Table 115. Gerresheimer Shuangfeng Recent Developments
  • Table 116. Jinghua Group Basic Information List
  • Table 117. Jinghua Group Description and Business Overview
  • Table 118. Jinghua Group Pharmaceutical Primary Inner Packaging Products, Services and Solutions
  • Table 119. Revenue (US$ Million) in Pharmaceutical Primary Inner Packaging Business of Jinghua Group (2020-2025)
  • Table 120. Jinghua Group Recent Developments
  • Table 121. Linuo Pharmaceutical Packaging Basic Information List
  • Table 122. Linuo Pharmaceutical Packaging Description and Business Overview
  • Table 123. Linuo Pharmaceutical Packaging Pharmaceutical Primary Inner Packaging Products, Services and Solutions
  • Table 124. Revenue (US$ Million) in Pharmaceutical Primary Inner Packaging Business of Linuo Pharmaceutical Packaging (2020-2025)
  • Table 125. Linuo Pharmaceutical Packaging Recent Developments
  • Table 126. Jiyuan Zhengyu Basic Information List
  • Table 127. Jiyuan Zhengyu Description and Business Overview
  • Table 128. Jiyuan Zhengyu Pharmaceutical Primary Inner Packaging Products, Services and Solutions
  • Table 129. Revenue (US$ Million) in Pharmaceutical Primary Inner Packaging Business of Jiyuan Zhengyu (2020-2025)
  • Table 130. Jiyuan Zhengyu Recent Developments
  • Table 131. EHUA Basic Information List
  • Table 132. EHUA Description and Business Overview
  • Table 133. EHUA Pharmaceutical Primary Inner Packaging Products, Services and Solutions
  • Table 134. Revenue (US$ Million) in Pharmaceutical Primary Inner Packaging Business of EHUA (2020-2025)
  • Table 135. EHUA Recent Developments
  • Table 136. Key Raw Materials Lists
  • Table 137. Raw Materials Key Suppliers Lists
  • Table 138. Pharmaceutical Primary Inner Packaging Downstream Customers
  • Table 139. Pharmaceutical Primary Inner Packaging Distributors List
  • Table 140. Research Programs/Design for This Report
  • Table 141. Key Data Information from Secondary Sources
  • Table 142. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Pharmaceutical Primary Inner Packaging Product Picture
  • Figure 2. Global Pharmaceutical Primary Inner Packaging Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Pharmaceutical Primary Inner Packaging Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Pharmaceutical Primary Inner Packaging Report Years Considered
  • Figure 5. Global Pharmaceutical Primary Inner Packaging Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Pharmaceutical Primary Inner Packaging Revenue in 2024
  • Figure 7. Pharmaceutical Primary Inner Packaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Glass Packaging Picture
  • Figure 9. Plastic Packaging Picture
  • Figure 10. Metal Packaging Picture
  • Figure 11. Global Pharmaceutical Primary Inner Packaging Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 12. Global Pharmaceutical Primary Inner Packaging Sales Value Market Share by Type, 2024 & 2031
  • Figure 13. Product Picture of Biopharmaceuticals
  • Figure 14. Product Picture of Chemical Pharmaceuticals
  • Figure 15. Global Pharmaceutical Primary Inner Packaging Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 16. Global Pharmaceutical Primary Inner Packaging Sales Value Market Share by Application, 2024 & 2031
  • Figure 17. North America Pharmaceutical Primary Inner Packaging Sales Value (2020-2031) & (US$ Million)
  • Figure 18. North America Pharmaceutical Primary Inner Packaging Sales Value by Country (%), 2024 VS 2031
  • Figure 19. Europe Pharmaceutical Primary Inner Packaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 20. Europe Pharmaceutical Primary Inner Packaging Sales Value by Country (%), 2024 VS 2031
  • Figure 21. Asia Pacific Pharmaceutical Primary Inner Packaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 22. Asia Pacific Pharmaceutical Primary Inner Packaging Sales Value by Region (%), 2024 VS 2031
  • Figure 23. South America Pharmaceutical Primary Inner Packaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 24. South America Pharmaceutical Primary Inner Packaging Sales Value by Country (%), 2024 VS 2031
  • Figure 25. Middle East & Africa Pharmaceutical Primary Inner Packaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 26. Middle East & Africa Pharmaceutical Primary Inner Packaging Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Key Countries/Regions Pharmaceutical Primary Inner Packaging Sales Value (%), (2020-2031)
  • Figure 28. United States Pharmaceutical Primary Inner Packaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. United States Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
  • Figure 30. United States Pharmaceutical Primary Inner Packaging Sales Value by Application (%), 2024 VS 2031
  • Figure 31. Europe Pharmaceutical Primary Inner Packaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Europe Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
  • Figure 33. Europe Pharmaceutical Primary Inner Packaging Sales Value by Application (%), 2024 VS 2031
  • Figure 34. China Pharmaceutical Primary Inner Packaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. China Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
  • Figure 36. China Pharmaceutical Primary Inner Packaging Sales Value by Application (%), 2024 VS 2031
  • Figure 37. Japan Pharmaceutical Primary Inner Packaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. Japan Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
  • Figure 39. Japan Pharmaceutical Primary Inner Packaging Sales Value by Application (%), 2024 VS 2031
  • Figure 40. South Korea Pharmaceutical Primary Inner Packaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. South Korea Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
  • Figure 42. South Korea Pharmaceutical Primary Inner Packaging Sales Value by Application (%), 2024 VS 2031
  • Figure 43. Southeast Asia Pharmaceutical Primary Inner Packaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. Southeast Asia Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
  • Figure 45. Southeast Asia Pharmaceutical Primary Inner Packaging Sales Value by Application (%), 2024 VS 2031
  • Figure 46. India Pharmaceutical Primary Inner Packaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. India Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
  • Figure 48. India Pharmaceutical Primary Inner Packaging Sales Value by Application (%), 2024 VS 2031
  • Figure 49. Pharmaceutical Primary Inner Packaging Industrial Chain
  • Figure 50. Pharmaceutical Primary Inner Packaging Manufacturing Cost Structure
  • Figure 51. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 52. Bottom-up and Top-down Approaches for This Report
  • Figure 53. Data Triangulation
  • Figure 54. Key Executives Interviewed